Clinical Trials Logo

Clinical Trial Summary

The objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each patient with Parkinson's disease, compared to conventional high-frequency rTMS therapy on bilateral primary motor cortex (M1). Investigators hypothesized that the functional reserve of each patient with Parkinson's disease will be different, and therefore an appropriate simulating target for rTMS therapy is needed. In addition, this approach could be more effective compared to conventional protocols applied to patient with Parkinson's disease regardless of their severity, predicted mechanism of motor function recovery, or functional reserves.


Clinical Trial Description

rTMS treatment for patients with Parkinson's disease is traditionally based on stimulating the neural network of brain. The widely-used traditional rTMS treatment protocol involves high-frequency stimulation over the bilateral primary motor cortex (M1) to enhance motor and gait functions. However, concerns have arisen regarding the effect of rTMS on motor recovery in patients with Parkinson's disease. Although still subject to debate, a possible reason for the diverse results of rTMS applied is the uniform application protocol to individuals with varying pathologies and functional reserves, aimed at enhancing recovery. Therefore, this study was aimed to determine the effects of protocols of rTMS therapy based on the functional reserve of each patient with Parkinson's disease. Based on screening evaluations (Timed Up and Go Test (TUG), Timed Up and Go Dual Task-Cognitive (TUG-Cog)), investigators hypothesized that patients could be categorized into two groups: 1) priority in motor functional reserve, 2) priority in cognitive functional reserve. For each group, investigators plan to randomly assign patients to experimental and control groups to demonstrate the efficacy of different rTMS protocols based on functional reserves compared to conventional high-frequency rTMS applied to the bilateral M1. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06350617
Study type Interventional
Source Samsung Medical Center
Contact Won Hyuk Chang, PhD
Phone +82-2-3410-6068
Email wh.chang@samsung.com
Status Recruiting
Phase N/A
Start date February 20, 2024
Completion date September 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT06037590 - A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA® Phase 1
Enrolling by invitation NCT04799418 - STEM-PD Open Label Extension (OLE) N/A
Not yet recruiting NCT06074393 - Caregiving in Advanced PD: A Tailored Support Group N/A
Completed NCT05699161 - Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson Phase 1/Phase 2
Not yet recruiting NCT05599659 - The Calgary Movement Disorders Advanced Care Pilot Program N/A
Completed NCT04140708 - Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's Disease N/A
Recruiting NCT03924414 - Trial of Parkinson's And Zoledronic Acid Phase 4
Recruiting NCT06203106 - NYSCF Scientific Discovery Biobank
Recruiting NCT04797611 - STEM-Parkinson's Disease N/A
Not yet recruiting NCT06174948 - The Use of the CUE1 in People With Parkinson's Disease and Related Disorders N/A
Enrolling by invitation NCT04701177 - Digitally-enhanced, Decentralized, Multi-omics Observational Cohort
Recruiting NCT05962489 - Sleep-specific DBS Therapy in Parkinson's Disease N/A
Recruiting NCT05931692 - Virtual Reality and Fear of Falling in Parkinson's Disease
Recruiting NCT04468919 - Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit N/A
Completed NCT04925622 - Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
Recruiting NCT04214509 - LIPAD - LRRK2 International Parkinson's Disease Study
Active, not recruiting NCT05677633 - Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease Phase 1
Recruiting NCT06247423 - High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease. N/A
Completed NCT05194748 - Diaphragmatic Thickness and Pulmonary Function in Parkinson's Disease
Recruiting NCT05320250 - Saliva and Extracellular Vesicles for Parkinson's Disease